The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LAMIVUDINE.     Injury: Condition aggravated     Quarter: 2016Q3

Total Records: 9     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
125823291 LAMIVUDINE. Condition aggravated CIPLA 0.00 0 20160722 CN
126915911 LAMIVUDINE. Condition aggravated GLAXOSMITHKLINE 47.00 YR M 0 20160826 CN
126927321 LAMIVUDINE. Condition aggravated CIPLA 0.00 0 20160829 IT
126932431 LAMIVUDINE. Condition aggravated VIIV 47.00 YR M 0 20160829 CN
127028581 LAMIVUDINE. Condition aggravated VIIV 0.00 F 0 20160831 MZ
127029621 LAMIVUDINE. Condition aggravated GLAXOSMITHKLINE 0.00 F 0 20160831 MZ
127200661 LAMIVUDINE. Condition aggravated VIIV 56.00 YR M 0 20160907 CN
127203091 LAMIVUDINE. Condition aggravated GLAXOSMITHKLINE 56.00 YR M 0 20160907 CN
128000801 LAMIVUDINE. Condition aggravated GLAXOSMITHKLINE 42.00 YR M 0 20160930 CN

Total Records: 9     Number of Pages: 1